Tuesday, December 12, 2017 12:56:21 AM
.
-Data readout dose selection studies ARS-H12017
-Contract with U.S government for ARS-H2/2017
-Initiation of pivotal study ARS NHP- H2/2017
-Data read out phase 1 open label HCT-H2/2017
-Preclinical data Fukushima-H1/17
-Preclinical data NYBC H1/2017
One out of six. That's acceptable right? That's what you want from management right? Experience really isn't important right? Huge bonuses in the same year is an industry norm and perfectly justified when you are under a month away from missing 5 of your 6 beginning of the year milestones right? Give us 5 out of 6 and it would probably be a different story. Or the big one that would make a big difference.
What would be so wrong to actually come out and explain the delays in any or all of these. Two of them coming up on 6 months late. Nothing to worry about there. Just normal delays. Ya right. Pathetic management is what we are stuck with unfortunately. Just do a few scripted interviews and speeches and that should shut them up.
Someone once asked a philosophical question. Who's the bigger idiot? The idiot or the one who believes the idiot? Think about it... Go ahead and cut and copy it and try to poke fun. You know it's true. LMBO
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM